Osteoarthritis
Conference Coverage
Prednisolone scores for hand OA
ATLANTA – The approach “is for short course. Long-term steroids can have important side effects, like osteoporosis. We do not think this study...
From the Journals
Well-tolerated topical capsaicin formulation reduces knee OA pain
ATLANTA – A new vehicle formulation improves tolerability of capsaicin treatment.
Conference Coverage
Tanezumab posts higher safety event rate than NSAIDs over 1 year in hip, knee OA
ATLANTA – More safety events were seen with the higher 5-mg dose than with 2.5 mg.
Conference Coverage
OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors
ATLANTA – “For any individual patient, a single option may be chosen at a particular time point, perhaps with or without other options, and may be...
Conference Coverage
Methotrexate may affect joint erosions but not pain in patients with erosive hand OA
ATLANTA – The results were observed for 10 mg methotrexate per week at 3 months and 12 months.
Conference Coverage
Cannabinoids, stem cells lack evidence for osteoarthritis, expert says
The treatments may interest patients, but are unsupported by the literature.
Conference Coverage
Consider centralized pain in patients with rheumatic disease
LAS VEGAS – Every patient with chronic pain should complete a fibromyalgia survey, Dr. Daniel J. Clauw says.
From the Journals
Cannabidiol may interact with rheumatologic drugs
CBD is known to inhibit the cytochrome P450 enzymes that metabolize corticosteroids and other medications.
From the Journals
Hemophilia carriers face elevated risk of joint comorbidities
Individuals who carry hemophilia genes and have reduced clotting factor activity also have a higher risk of joint-related comorbidities.
Conference Coverage
PROMIS tools provide useful data for managing rheumatology patients
LAKE BUENA VISTA, FLA. – The NIH PROMIS tools provide helpful, trackable data that can improve the care of rheumatology patients.
From the Journals
NSAIDs a significant mediator of cardiovascular risk in osteoarthritis
NSAID use could be responsible for a significant proportion of the increased risk of cardiovascular disease associated with osteoarthritis.